Table 2.

Persistence of medications in the 2,698 high-risk stroke population.

	Hpertension (n = 1,949)	Diabetes (n = 721)	Dyslipidemia (n = 751)	History of stroke (n = 487)	Hpertension, diabetes, dyslipidemia and stroke at same time (n = 378)
Treatment at survey (n, %)	996 (51.1)	444 (61.6)	374 (46.2)	487 (100.0)	286 (75.7)
Treatment at 4.7 years after survey (n, %)	378 (19.4)	177 (24.5)	164(21.8)	291(59.8)	136 (36.0)
Persistence of therapy rate (n, %)	38.0 (378/996)	39.9 (177/444)	43.9 (164/374)	59.8 (291/487)	47.6 (136/286)